Pharma Knock-Offs, a Secret Email Address, and a Smooth Spin of the Revolving Door
By John A. Jenkins, Law St. Media, May 7, 2025
Questions about GLP-1 weight loss drugs, DOGE, cryptocurrencies, and the past conduct of Trump’s regulatory nominees are among those in newly available Freedom of Information Act requests filed by media organizations with the Food and Drug Administration, the Federal Trade Commission, and the Securities and Exchange Commission.
FOIA requests targeting those hot-button topics were among 339 queries filed by the news media in the past month with the three key regulators, as tracked in as close to real time as possible by PoliScio Analytics’ competitive-intelligence database FOIAengine.
Read more here.